Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Irritable Bowel Syndrome Treatment Market: By Type: IBS-C, IBS-D; By Application: Cardiology, Urology & Nephrology, Oncology, Gastroenterology; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments

Global Irritable Bowel Syndrome Treatment Market Outlook

The global irritable bowel syndrome treatment market attained a value of about USD 2 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of more than 10% to reach USD 3.2 billion in 2026.

 

The market is being driven by the increasing prevalence of target diseases and the expanded use of medicines for such diseases. The global market is being dominated by North America.

 

Irritable Bowel Syndrome Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Irritable bowel syndrome is among the most prevalent functional disorders, with an approximate global prevalence of 10-15%. The actual cause of the symptoms is not known, and symptoms may arise from changes in the activity of the brain, nervous system, and the gut. This can affect the regular feeling and function of the bowel.

 

Global Irritable Bowel Syndrome Treatment Market By Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on type, the industry can be divided into IBS-C and IBS-D.

IBS-C can be further divided into:

  • IBS-C Market
  • Linzess/Constella
  • Amitiza
  • Others

IBS-D is further segmented into:

  • Xifaxan
  • Viberzi
  • Others

The industry can be broadly categorised based on its applications into:

  • Cardiology
  • Urology and Nephrology
  • Oncology
  • Gastroenterology
  • Others

The EMR report looks into the regional markets of irritable bowel syndrome treatment like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Irritable Bowel Syndrome Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

Improved marketing of existing products in various regions is likely to boost the demand over the forecast period 2022-2027. The increasing Linzess adoption in the USA, Europe, as well as Japan, has contributed greatly to the growth of revenues. In January 2020, Linzess was approved in China, which is expected to improve the demand further.

IBS’ continually rising economic burden impacts the quality of jobs and results in higher healthcare costs. In addition, this increased awareness of the disease has, therefore, encouraged the growth of the global irritable bowel syndrome treatment industry. However, the high prevalence of anxiety and depression is expected to catalyse the growth of the demand for irritable bowel syndrome over the forecast period.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global irritable bowel syndrome treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
  • Allergan 
  • Astellas Pharma Inc. 
  • Takeda Pharmaceutical Company Limited 
  • AstraZeneca 
  • Sebela Pharmaceuticals Inc. [Sebela International, Ltd]
  • Synergy Pharmaceuticals Inc. [Callisto Pharmaceuticals, Inc.]
  • Synthetic Biologics, Inc. 
  • Bausch Health Companies Inc. 
  • Ardelyx (NASDAQ: ARDX)
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and
Forecast Market Analysis by Segment- Type, Application, Region
Breakup by Type IBS-C, IBS-D
Breakup by Application Cardiology, Urology & Nephrology, Oncology, Gastroenterology, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Ironwood Pharmaceuticals, Inc. [IRWD (NASDAQ)], Allergan [AGN (NYSE)], Astellas
Pharma Inc. [4503 (TYO)], Takeda Pharmaceutical Company Limited [4502 (TYO)],
AstraZeneca [AZN (LON)], Sebela Pharmaceuticals Inc. [Sebela International, Ltd],
Synergy Pharmaceuticals Inc. [Callisto Pharmaceuticals, Inc.], Synthetic Biologics, Inc.
[SYN (NYSEAMERICAN)], Bausch Health Companies Inc. [BHC (TSE)], Ardelyx [ARDX (NASDAQ)], Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Irritable Bowel Syndrome Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Irritable Bowel Syndrome Treatment Historical Market (2017-2021) 
    8.3    Global Irritable Bowel Syndrome Treatment Market Forecast (2022-2027)
    8.4    Global Irritable Bowel Syndrome Treatment Market by Type
        8.4.1    IBS-C
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    IBS-C Market
                8.4.1.4.2    Linzess/Constella
                8.4.1.4.3    Amitiza
                8.4.1.4.4    Others
        8.4.2    IBS-D
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Xifaxan 
                8.4.2.4.2    Viberz
                8.4.2.4.3    Others
    8.5    Global Irritable Bowel Syndrome Treatment Market by Application
        8.5.1    Cardiology
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Urology & Nephrology
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Oncology
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Gastroenterology
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Others
    8.6    Global Irritable Bowel Syndrome Treatment Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Ironwood Pharmaceutical, Inc.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Allergan
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Astellas Pharma Inc.
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Takeda Pharmaceutical Company Limited
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    AstraZeneca
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Sebela Pharmaceuticals Inc.
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Synergy Pharmaceutical Inc.
            11.2.7.1    Company Overview
            11.2.7.2    Product Portfolio
            11.2.7.3    Demographic Reach and Achievements
            11.2.7.4    Certifications
        11.2.8    Synthetic Biologics, Inc.
            11.2.8.1    Company Overview
            11.2.8.2    Product Portfolio
            11.2.8.3    Demographic Reach and Achievements
            11.2.8.4    Certifications
        11.2.9    Bausch Health Companies Inc.
            11.2.9.1    Company Overview
            11.2.9.2    Product Portfolio
            11.2.9.3    Demographic Reach and Achievements
            11.2.9.4    Certifications
        11.2.10    Ardelyx
            11.2.10.1    Company Overview
            11.2.10.2    Product Portfolio
            11.2.10.3    Demographic Reach and Achievements
            11.2.10.4    Certifications
        11.2.11    Others
12    Industry Events and Developments


List of Key Figures and Tables

1.    Global Irritable Bowel Syndrome Treatment Market: Key Industry Highlights, 2017 and 2027
2.    Global Irritable Bowel Syndrome Treatment Historical Market: Breakup by Type (USD Million), 2017-2021
3.    Global Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Type (USD Million), 2022-2027
4.    Global Irritable Bowel Syndrome Treatment Historical Market: Breakup by Application (USD Million), 2017-2021
5.    Global Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Application (USD Million), 2022-2027
6.    Global Irritable Bowel Syndrome Treatment Historical Market: Breakup by Region (USD Million), 2017-2021
7.    Global Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Region (USD Million), 2022-2027
8.    North America Irritable Bowel Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
9.    North America Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
10.    Europe Irritable Bowel Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Europe Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Asia Pacific Irritable Bowel Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Asia Pacific Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Latin America Irritable Bowel Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Latin America Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Middle East and Africa Irritable Bowel Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Middle East and Africa Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Global Irritable Bowel Syndrome Treatment Market Structure

Key Questions Answered in the Report

In 2020, the global irritable bowel syndrome treatment market attained a value of nearly USD 2 billion.

The market is projected to grow at a CAGR of 10% between 2022 and 2027.

The market is being driven by the rising prevalence of irritable bowel syndrome owing to changes in brain, nervous system, or the gut.

The market growth in the forecast period can be associated with the rising awareness of irritable bowel syndrome and the corresponding measures undertaken for effective treatment.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major types of irritable bowel syndrome treatment are IBS-C and IBS-D.

The significant applications of irritable bowel syndrome treatment include cardiology, urology and nephrology, oncology, and gastroenterology, among others.

The major players in the industry are Ironwood Pharmaceuticals, Inc., Allergan, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, AstraZeneca, Sebela Pharmaceuticals Inc., Synergy Pharmaceuticals Inc., Synthetic Biologics, Inc., Bausch Health Companies Inc., and Ardelyx, among others.

Analyst Review

The global irritable bowel syndrome treatment market attained a value of about USD 2 billion in 2020, driven by the rising prevalence of irritable bowel syndrome. Aided by rising awareness regarding irritable bowel syndrome, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 10%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on type, the irritable bowel syndrome treatment industry can be divided into IBS-C and IBS-D. On the basis of application, the market can be segmented into cardiology, urology and nephrology, oncology, and gastroenterology, among others. The major regional markets for irritable bowel syndrome treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Ironwood Pharmaceuticals, Inc., Allergan, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, AstraZeneca, Sebela Pharmaceuticals Inc., Synergy Pharmaceuticals Inc., Synthetic Biologics, Inc., Bausch Health Companies Inc., and Ardelyx, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER